CLINDAMYCIN PHOSPHATE AND TRETINOIN

Post-LOE

clindamycin phosphate and tretinoin gel 1.2%/0.025%

ANDATOPICALGEL

Approved

Sep 2023

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

2/8 — Basic

CLINDAMYCIN PHOSPHATE AND TRETINOIN (clindamycin phosphate and tretinoin gel 1.2%/0.025%) is : [see microbiology (). First approved in 2023.

Drug data last refreshed 21h ago

Mechanism of Action

: [See Microbiology ().] Tretinoin : Although the exact mode of action of tretinoin is unknown, current evidence suggests that topical tretinoin decreases cohesiveness of follicular epithelial cells with decreased microcomedone formation. Additionally, tretinoin stimulates mitotic activity and…

Pharmacologic Class:

Retinoid

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

External Resources

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.